These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31797436)

  • 1. A low-cost laboratory-based method for predicting newly diagnosed biopsy-proven diabetic nephropathy in people with type 2 diabetes.
    Yu D; Shang J; Cai Y; Wang Z; Zhao B; Zhao Z; Simmons D
    Diabet Med; 2020 Oct; 37(10):1728-1736. PubMed ID: 31797436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The triglyceride glucose index can predict newly diagnosed biopsy-proven diabetic nephropathy in type 2 diabetes: A nested case control study.
    Shang J; Yu D; Cai Y; Wang Z; Zhao B; Zhao Z; Simmons D
    Medicine (Baltimore); 2019 Nov; 98(46):e17995. PubMed ID: 31725665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of diabetic nephropathy with variation in hemoglobin A1c and fasting plasma glucose.
    Lin CC; Chen CC; Chen FN; Li CI; Liu CS; Lin WY; Yang SY; Lee CC; Li TC
    Am J Med; 2013 Nov; 126(11):1017.e1-10. PubMed ID: 23993260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation and external validation of a risk prediction algorithm to estimate future risk of cardiovascular death among patients with type 2 diabetes and incident diabetic nephropathy: prospective cohort study.
    Yu D; Shang J; Cai Y; Wang Z; Zhang X; Zhao B; Zhao Z; Simmons D
    BMJ Open Diabetes Res Care; 2019; 7(1):e000735. PubMed ID: 31798896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomogram for the prediction of diabetic nephropathy risk among patients with type 2 diabetes mellitus based on a questionnaire and biochemical indicators: a retrospective study.
    Hu Y; Shi R; Mo R; Hu F
    Aging (Albany NY); 2020 Jun; 12(11):10317-10336. PubMed ID: 32484786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors.
    Svensson MK; Tyrberg M; Nyström L; Arnqvist HJ; Bolinder J; Östman J; Gudbjörnsdottir S; Landin-Olsson M; Eriksson JW
    Diabetes Metab Res Rev; 2015 Feb; 31(2):138-46. PubMed ID: 25044633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of Irisin Hormone Level in Type 2 Diabetic Patients and Patients with Diabetic Nephropathy.
    Shelbaya S; Abu Shady MM; Nasr MS; Bekhet MM; Mageed YA; Abbas M
    Curr Diabetes Rev; 2018; 14(5):481-486. PubMed ID: 28875825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting non-diabetic renal disease in type 2 diabetic adults: The value of glycated hemoglobin.
    Pallayova M; Mohammed A; Langman G; Taheri S; Dasgupta I
    J Diabetes Complications; 2015 Jul; 29(5):718-23. PubMed ID: 25633572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinicopathological characteristics of diabetic nephropathy and non-diabetic renal diseases in diabetic patients].
    Xu J; Hu XF; Huang W; Shen PY; Zhang W; Ren H; Li X; Wang WM; Chen N; Pan XX
    Zhonghua Nei Ke Za Zhi; 2017 Dec; 56(12):924-929. PubMed ID: 29202533
    [No Abstract]   [Full Text] [Related]  

  • 10. Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus.
    Wang N; Xu Z; Han P; Li T
    Diabetes Metab Res Rev; 2017 Feb; 33(2):. PubMed ID: 27537245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline.
    Misra PS; Szeto SG; Krizova A; Gilbert RE; Yuen DA
    BMC Nephrol; 2020 Jul; 21(1):285. PubMed ID: 32682403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for diabetic nephropathy complications in community patients with type 2 diabetes mellitus in Shanghai: Logistic regression and classification tree model analysis.
    Lou J; Jing L; Yang H; Qin F; Long W; Shi R
    Int J Health Plann Manage; 2019 Jul; 34(3):1013-1024. PubMed ID: 31368138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High incidence of diabetic nephropathy in early-onset Japanese NIDDM patients. Risk analysis.
    Yokoyama H; Okudaira M; Otani T; Watanabe C; Takaike H; Miuira J; Yamada H; Mutou K; Satou A; Uchigata Y; Iwamoto Y
    Diabetes Care; 1998 Jul; 21(7):1080-5. PubMed ID: 9653599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus.
    Huang JX; Liao YF; Li YM
    Curr Med Sci; 2019 Oct; 39(5):754-758. PubMed ID: 31612393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of diabetic nephropathy in patients with type 2 diabetes mellitus at a tertiary healthcare setting in Ethiopia.
    Tamru K; Aga F; Berhanie E; Aynalem YA; Shiferaw WS
    Diabetes Metab Syndr; 2020; 14(5):1077-1083. PubMed ID: 32650279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between diabetic retinopathy and nephropathy in Sudanese adult with diabetes: population based study.
    Ahmed MH; Elwali ES; Awadalla H; Almobarak AO
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S333-S336. PubMed ID: 28325541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of diabetes mellitus several years after manifestation of diabetic nephropathy: case report and review of literature.
    Siraj ES; Myles J; Nurko S; Mehta AE; Reddy SS
    Endocr Pract; 2003; 9(4):301-6. PubMed ID: 14561575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical predictors differentiating non-diabetic renal diseases from diabetic nephropathy in a large population of type 2 diabetes patients.
    Dong Z; Wang Y; Qiu Q; Zhang X; Zhang L; Wu J; Wei R; Zhu H; Cai G; Sun X; Chen X
    Diabetes Res Clin Pract; 2016 Nov; 121():112-118. PubMed ID: 27693840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. When to perform renal biopsy in patients with type2 diabetes mellitus? Predictive model of non-diabetic renal disease.
    García-Martín F; González Monte E; Hernández Martínez E; Bada Boch T; Bustamante Jiménez NE; Praga Terente M
    Nefrologia (Engl Ed); 2020; 40(2):180-189. PubMed ID: 31761446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-diabetic nephropathy in diabetic patients: incidence, HbA1c variability and other predictive factors, and implications.
    Demirelli B; Boztepe B; Şenol EG; Boynueğri B; Bildacı YD; Gümrükçü G; Canbakan M; Öğütmen MB
    Int Urol Nephrol; 2024 Sep; 56(9):3091-3100. PubMed ID: 38662267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.